BioCryst Pharma (BCRX) Misses Q2 EPS by 1c

August 3, 2023 7:04 AM EDT
Get Alerts BCRX Hot Sheet
Price: $8.81 --0%

Financial Fact:
Total revenues: 7.76M

Today's EPS Names:
SUJA, SQNS, ANGI, More
Join SI Premium – FREE

BioCryst Pharma (NASDAQ: BCRX) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $81 million versus the consensus estimate of $81.41 million.

For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings